Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neurilemmoma 1Neoplasms 1Meningioma 1Lung Neoplasms 1Low Grade Glioma of Brain 1Inflammatory Bowel Diseases 1Inflammation 1Glioma 1Colorectal Neoplasms 1Brain Neoplasms 1

Interventions

Temozolomide 162Radiosurgery 115Radiotherapy 100Bevacizumab 96Magnetic Resonance Spectroscopy 65Carboplatin 48Etoposide 34pembrolizumab 33Surgical Procedures, Operative 33Irinotecan 33Nivolumab 32Cyclophosphamide 32Erlotinib Hydrochloride 31Radiation 30Carmustine 28Lomustine 25Cisplatin 25Trastuzumab 23Ipilimumab 23Filgrastim 23Vincristine 20Mental Status and Dementia Tests 20Aminolevulinic Acid 19Topotecan 18Pemetrexed 18Capecitabine 18Specimen Handling 17Sorafenib 15Radiotherapy, Intensity-Modulated 15Imatinib Mesylate 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Brain Neoplasms × Hyperspectral Imaging × Clear all
NCT04712214 2023-04-25

Use of Non-invasive Optical Analysis in Neurosurgery

Imperial College London

Phase NA Unknown
50 enrolled
CNS

Brain Neoplasms, Glioma, Meningioma, Neurilemmoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡